pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$BPTHBIO-PATH HOLDINGS, INC.

$BPTH
Bellaire, TX, USupdated 2mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
4
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(4)

pipeline depth4 products
Preclinical: 1Phase 1: 2Phase 2: 1
1Preclinical2Phase 11Phase 2
Phase 2
prexigebersen
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Growth factor receptor-bound protein 2 mRNA
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
Phase 1
prexigebersen-A
Breast Cancer
Preclinical
BP-1003
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase1A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)recruitingn=48
  • phase1BP1001-A in Patients With Advanced or Recurrent Solid Tumorsrecruitingn=50
  • phase2Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLrecruitingn=108
  • phase1A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignanciesactive not recruitingn=30
🐶 Hiring Signal
No open roles indexed yet — view BIO-PATH HOLDINGS, INC. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$BPTH
SEC CIK
0001133818
country
US
source
sec_tickers
top tags
Oncology3NSCLC1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?